Clinical Trial Update: The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Kinisoquin™ for reducing thromboembolic events in patients with metastatic or locally advanced pancreatic cancer; study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Kinisoquin™

Snippet

Sponsor: Quercis Pharma AG | Conditions: Venous Thromboembolism, Metastatic Pancreatic Cancer | Phase 3 | Status: RECRUITING